Viracta Therapeutics Company

Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.

Funding Status: IPO
Industry: Biopharma, Biotechnology, Medical, Pharmaceutical, Therapeutics
Estimated Revenue: $10M to $50M
Technology: Cancer
Headquarters: Cardiff By The Sea, California, United States
Total Funding: 184899999
Last Funding Date: 2021
Last Funding Type: Post-IPO Equity
Investor Type: IPO
Employee Number: 11-50
Investors Number: 19
Founded Date: 2007